SERPINB2 and head and neck squamous cell carcinoma: A study conducted to identify the molecular determinants of chemoresistance in HNSCC employing genome-wide gene expression analysis revealed SERPINB2 as a pivotal candidate contributing to the drug-resistant phenotype.